Announcements Trials

Browse Landscape

Phase

Phase 2 19 Phase 1 17 Phase 1/2 12 Phase 3 11 Phase NA 7 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Squamous Cell Carcinoma of Head and Neck 8 Neoplasms 6 Stomach Neoplasms 5 Prostatic Neoplasms 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Oropharyngeal Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Fatigue 4 Urinary Bladder Neoplasms 3 Recurrence 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Myasthenia Gravis 3 Mouth Neoplasms 3 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Weight Loss 2 Peritoneal Neoplasms 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Squamous Cell 2

Interventions

olaparib 1 durvalumab 1 Progestins 1 Paclitaxel 1 Observation 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Drug Therapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Endometrial Neoplasms × 30 days × Clear all

NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡